We are live on ! Find out more
SER icon

Serina Therapeutics
SER

56 hedge funds and large institutions have $13.1M invested in Serina Therapeutics in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

10% more funds holding

Funds holding: 51 → 56 (+5)

0.02% more ownership

Funds ownership: 0.48% → 0.5% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

44% less capital invested

Capital invested by funds: $23.3M → $13.1M (-$10.2M)

Holders
56
Holders Change
+5
Holders Change %
+9.8%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
17
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$304K
2
State Street
State Street
Massachusetts
+$209K
3
PAM
Panagora Asset Management
Massachusetts
+$178K
4
BlackRock
BlackRock
New York
+$86.6K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$83.5K

Top Sellers

Rank Fund Capital Flow
1
DC
Defender Capital
North Carolina
-$156K
2
Jane Street
Jane Street
New York
-$99K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$30.4K
4
Deutsche Bank
Deutsche Bank
Germany
-$27K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$13.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWCS
26
Beirne Wealth Consulting Services
Connecticut
$24K – – –
ISB
27
Iowa State Bank
Iowa
$22K – – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$21K -$30.4K -321 -52%
Barclays
29
Barclays
United Kingdom
$21K -$8.73K -92 -23%
Bank of America
30
Bank of America
North Carolina
$18K -$474 -5 -2%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$14K – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$14K +$3.04K +32 +19%
Deutsche Bank
33
Deutsche Bank
Germany
$10K -$27K -285 -63%
Legal & General Group
34
Legal & General Group
United Kingdom
$7K – – –
Victory Capital Management
35
Victory Capital Management
Texas
$7K +$10.1K +107 New
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$5K +$285 +3 +5%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$4.34K +$2.75K +29 +85%
BDS
38
Banco de Sabadell
Florida
$4K – – –
Citigroup
39
Citigroup
New York
$3K -$12.9K -136 -75%
RAM
40
Riggs Asset Management
Pennsylvania
$2K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$2K +$1.8K +19 +158%
Fidelity Investments
42
Fidelity Investments
Massachusetts
$2K +$2.66K +28 New
RE
43
RBC Europe
United Kingdom
$1.12K – – –
AIP
44
Ameritas Investment Partners
Nebraska
$1K – – –
FANJ
45
Financial Architects (New Jersey)
New Jersey
$1K – – –
HPC
46
HM Payson & Co
Maine
$1K – – –
MAM
47
Meeder Asset Management
Ohio
$1K +$474 +5 +38%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$1K +$569 +6 +38%
Jane Street
49
Jane Street
New York
– -$99K -771 Closed
AIC
50
Ameritas Investment Company
Nebraska
– +$854 +9 New
1
2

SER Hedge Fund Activity: Q3 2019 in Review

56 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2019, worth a combined $13.1M — down 44% from $23.3M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SER positions and 2 closed out — a net gain of 5 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was Northern Trust, adding an estimated $304K. The largest seller was Defender Capital, cutting an estimated $156K.

  • 56 institutional investors held Serina Therapeutics (SER) as of Q3 2019, up from 51 in Q2 2019.
  • Funds reported $13.1M of Serina Therapeutics stock for Q3 2019, down 44% quarter-over-quarter.
  • 7 funds opened new Serina Therapeutics positions in Q3 2019 and 2 closed out, a net change of +5 holders.
  • The largest Serina Therapeutics buyer in Q3 2019 was Northern Trust, an estimated $304K added.
  • The largest Serina Therapeutics seller in Q3 2019 was Defender Capital, an estimated $156K sold.

Based on aggregated 13F filings for Q3 2019.